Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2009
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/17/2009CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009CA2411368C Therapeutic combinations of fatty acids
11/17/2009CA2402524C Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/12/2009US20090281370 In vitro fertilisation
11/12/2009US20090281114 Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
11/12/2009US20090281096 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/12/2009US20090281087 Compounds II
11/11/2009EP2116264A1 Preparation for transnasal application
11/11/2009EP2116250A1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
11/11/2009EP2116249A1 Pharmaceutical compound containing gestagens and/or oestrogens and 5-methyl-(6S)-tetrahydrofolates
11/11/2009EP2114412A2 Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
11/11/2009EP2114147A2 Reducing side effects of tramadol
11/11/2009EP1490120B1 Embolization
11/11/2009EP1317286B1 Administration form for hormonal contraception
11/11/2009EP1158976B1 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
11/11/2009CN101578098A Drug, drug induction device, magnetic detector and method of designing drug
11/11/2009CN101575607A Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression
11/11/2009CN101574522A Vagina slowly-releasing administration system
11/11/2009CN101574504A Medical composition for treating mammary gland diseases and preparation method thereof
11/11/2009CN101574477A Method for controlling quality of menstruation regulation and macula removal tablet
11/11/2009CN101574463A Method for controlling quality of Fuke Zhixueling capsule
11/11/2009CN101574459A Fuyan pill
11/11/2009CN101574458A Traditional Chinese medicine preparation for curing impotence due to kidney deficiency
11/11/2009CN101574455A Mongolian dandelion herb and parslane herb decoction used for clearing away acute mastitis
11/11/2009CN101574428A Vagina repair gel and preparation method thereof
11/11/2009CN101574417A Gender self-selection drug
11/11/2009CN101574408A Traditional Chinese medicine composition and preparation thereof for health care and beautification
11/11/2009CN101574395A Method for producing schisandra extract by adopting high voltage pulse electric field technology
11/11/2009CN101574390A Chinese medicinal composition for treating irregular menstruation
11/11/2009CN101574378A Chinese medicament for treating woman uterine bleeding
11/11/2009CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing
11/11/2009CN101574349A Pharmaceutical composition of curing endometriosis uterina
11/11/2009CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009CN101574321A Ketoconazole vaginal tablet and preparation method thereof
11/11/2009CN101574144A Application of 3'-deoxyadenosine in reducing weight, enhancing insulin sensitivity and improving lipid metabolism
11/11/2009CN100558741C 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/11/2009CN100558384C Medicine composition for treating mammary gland hyperplasia and its extracting preparing method
11/11/2009CN100558357C Medicine composition for treating mixed infectious disease
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615547 Granulates containing liposoluble substances and a process for the preparation thereof
11/10/2009US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2186953C Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
11/05/2009WO2009134725A2 Compositions and methods for treating progesterone-dependent conditions
11/05/2009WO2009134718A1 Pregesteron antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
11/05/2009WO2009134713A1 Compositions and methods for male contraception
11/05/2009WO2009134383A2 Vinyl substituted fatty acids
11/05/2009WO2009133934A1 Agent for controlling labor pain, and agent for preventing or inhibiting premature birth
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009113108A3 Styrene maleic anhydride based formulation for male contraception and prostate cancer
11/05/2009US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009US20090275507 Contraceptive composition
11/05/2009US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009CA2729053A1 Vinyl substituted fatty acids
11/05/2009CA2722753A1 Pregesteron antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1490121B1 Drug delivery particle
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1467743B1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders
11/04/2009CN101569687A Herbal medicine for osteoporosis and related conditions
11/03/2009US7612114 Selective estrogen receptor modulator
11/03/2009US7612083 Urea substituted imidazoquinoline ethers
11/03/2009US7612047 Degradation-resistant mononucleoside phosphate compounds
11/03/2009CA2409926C Praziquantel compounds for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
11/03/2009CA2383220C Controlled release pellet formulation
11/03/2009CA2372668C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
11/03/2009CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
11/03/2009CA2353133C Treatment of disorders secondary to organic impairments
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
10/2009
10/29/2009WO2009131191A1 Metastin derivative and use thereof
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009US20090270381 Non-steroidal progesterone receptor modulators
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090269426 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
10/29/2009US20090269298 Agent for the prevention and treatment of sexually transmitted diseases-i
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP2111870A1 Dosages for treatment of anti-erbB2 antibodies
10/28/2009CN101568330A Methods for the preparation of biologically active compounds in nanoparticulate form
10/28/2009CN101564531A Hormone injection capable of adjusting and controlling the puberty start of sow
10/28/2009CN101564523A Traditional Chinese medicine for curing female infertility
10/28/2009CN101564521A External plaster for treating hyperplasia of mammary glands
10/28/2009CN101564496A Plaster for mainly curing osteoarthropathy and soft tissue injury
10/28/2009CN101564486A Medicament for preventing and treating ruminant post-natal diseases and preparation method thereof
10/28/2009CN101564484A Chinese traditional medicine combination for treating mastosis and preparing method
10/28/2009CN101564483A Liver smoothing granule and application of same for treating hyperplasia of mammary glands